If you or a loved one was harmed by a dangerous drug, you may be wondering whether defective-product liability laws let you sue the pharmaceutical manufacturer that made it. The short answer is yes — and the stakes are enormous. The U.S. Food and Drug Administration receives more than 2 million serious adverse drug event reports each year through its FAERS database, and the Centers for Disease Control and Prevention estimates that adverse drug events cause roughly 1.3 million emergency department visits annually in the United States. California’s product liability law gives injured patients powerful tools to hold drug companies accountable, and our team at Compass Law Group, LLP has spent more than two decades doing exactly that.
What Makes a Pharmaceutical Drug “Defective” Under California Law?
California recognizes three legal theories of pharmaceutical defect, and a single drug can be defective under more than one of them at the same time. The first is a manufacturing defect — the drug as produced did not match its intended formula, perhaps because of contamination on the production line, an adulterated active ingredient, or incorrect dosing in the finished tablet. The second is a design defect, where the drug’s chemistry itself is unreasonably dangerous when used as intended. The third — and by far the most common in pharmaceutical litigation — is a failure-to-warn defect, where the manufacturer knew or should have known of a serious risk and did not adequately disclose it to physicians and consumers.
Because prescription drugs are sold through a “learned intermediary” (your physician), California courts apply a modified standard known as the comment k exception. That doesn’t immunize drug companies — it simply means a plaintiff usually proves the warning was inadequate rather than that the drug should never have been sold. A skilled defective-product lawyer will examine clinical trial data, post-market surveillance reports, internal company memos, and the drug’s labeling history to identify which theory fits your case best. Spanish-speaking clients can review the same information through our product liability attorney page in Spanish.
Common categories that have generated thousands of California lawsuits include blood thinners with bleeding risks, hormonal therapies linked to cancer, opioids marketed as non-addictive, weight-loss medications associated with cardiac injuries, heartburn drugs containing carcinogenic impurities, and medical-device-drug combinations such as drug-eluting stents. If your medication appears on an FDA recall list or carries a black-box warning that was added after you began taking it, that timing alone may support a claim.
Which California Statutes Govern Dangerous Drug Lawsuits?
The legal framework for suing a pharmaceutical manufacturer in California rests on a combination of common-law product liability doctrine and several specific statutes. The two-year filing deadline comes from California Code of Civil Procedure § 335.1, but the discovery rule can extend that period when the connection between drug and injury was not — and could not reasonably have been — known until later. For wrongful-death claims arising from a fatal medication injury, families have a separate two-year window from the date of death.
California Civil Code §§ 1709 and 1710 codify fraud and deceit causes of action that frequently appear in pharmaceutical cases when a manufacturer concealed known risks. Business and Professions Code § 17200 (the Unfair Competition Law) lets plaintiffs and the Attorney General pursue companies that engaged in deceptive marketing — a route used in major opioid settlements involving California cities and counties. And Civil Code § 3294 authorizes punitive damages where “clear and convincing evidence” shows malice, oppression, or fraud, which is often present when internal documents reveal the company knew about a danger and concealed it.
Federal law also matters. The FDA’s regulatory regime sets minimum labeling and manufacturing standards but does not preempt most California product-liability claims for generic-drug failure-to-warn or for branded design defects. If you live in Beverly Hills or anywhere else in the state, the same statutory framework applies — venue and trial court differ, but the underlying rights do not.
Who Can Be Held Liable Beyond the Drug Manufacturer?
One of the most important strategic decisions in a dangerous-drug case is identifying every defendant whose conduct contributed to the injury. California’s “stream of commerce” doctrine allows plaintiffs to name any party that profited from putting the dangerous drug into the patient’s hands, which often includes more than just the company whose name is on the bottle.
- Brand-name manufacturer — the company that designed the molecule, conducted clinical trials, and authored the original labeling, including any failure to update warnings as new risks emerged.
- Generic manufacturer — liable for manufacturing defects and, under recent California precedent, for certain design and marketing claims that don’t conflict with federal labeling rules.
- Distributors and wholesalers — particularly when chain-of-custody errors caused contamination or when bulk distributors ignored suspicious order patterns (a major theme in opioid litigation).
- Retail pharmacies — for dispensing errors, failure to counsel about known interactions, or filling prescriptions outside accepted standards of care.
- Sales representatives and marketing firms — when off-label promotion or misleading detailing materials drove inappropriate prescribing.
- Clinical trial organizations — for fraudulent or negligent trial conduct that obscured safety signals before approval.
- Hospitals and prescribers — though usually pursued under medical-malpractice rules rather than product liability, they may share fault for ignoring documented warnings.
If a fatal medication injury affected your family in the South Bay, our Long Beach Wrongful Death Attorney team can identify every responsible party. Patients on the Westside should reach out through our Beverly Hills Wrongful Death Lawyer page. Cases involving older patients in Northern California frequently come through our San Francisco office.
By the Numbers: California Pharmaceutical Product Liability Statistics
The scale of dangerous-drug harm — and the recoveries available — comes into focus when you look at the data. The figures below come from federal regulators, public-health agencies, and verified court records.
- 2,000,000+ serious adverse drug event reports are submitted to the FDA Adverse Event Reporting System (FAERS) each year, and a substantial share involve California patients (FDA FAERS public dashboard).
- 1,300,000 emergency department visits per year in the U.S. are caused by adverse drug events, according to the CDC Medication Safety Program.
- $26 billion — the approximate combined value of nationwide settlements in the multi-state opioid litigation, of which California cities, counties, and individuals received more than $2.05 billion.
- 3,500+ drug recalls have been logged on the FDA Enforcement Report database in the past five years, including dozens of Class I “reasonable probability of serious adverse health consequences” recalls.
- 2 years — the standard California statute of limitations for personal-injury claims against drug manufacturers under CCP § 335.1.
These numbers translate into real recoveries. Settlement and verdict ranges in California dangerous-drug cases vary widely, but life-changing injuries — kidney failure, stroke, cancer, cardiac events, suicide attributed to inadequately warned psychiatric medication — routinely produce six- and seven-figure outcomes, and class or mass-tort participation can add multiples to that.
How Much Is a California Dangerous-Drug Case Worth?
Compensation in a pharmaceutical defective-product case generally falls into three categories under California law. Economic damages include past and future medical bills, lost wages, lost earning capacity, home health care, prescription co-pays, and travel for specialized treatment. Non-economic damages compensate for pain, suffering, disfigurement, loss of enjoyment of life, and emotional distress; unlike medical-malpractice claims, product liability cases against drug manufacturers are not capped by MICRA. Punitive damages are available under Civil Code § 3294 when clear and convincing evidence shows the company acted with malice, oppression, or fraud — often documented through internal emails revealing concealed safety data.
Several factors drive the dollar value of a particular case: the severity and permanence of the injury, the patient’s age and earning trajectory, whether the drug caused cognitive damage requiring care from a specialized brain injury attorney, the strength of the warnings the company actually issued versus the warnings it should have issued, the existence of prior FDA inspections or recalls, the breadth of the population exposed, and whether your case proceeds individually, joins a Judicial Council Coordinated Proceeding (JCCP) in California state court, or becomes part of a federal Multi-District Litigation. Long Beach patients with significant lost-income claims should request an early vocational assessment, because that documentation often more than doubles a settlement.
Insurance and corporate-balance-sheet realities also matter. Major manufacturers carry product-liability towers running into the billions, and global settlements often allocate set amounts per injury “tier.” Working with a firm that has handled mass-tort allocation grids — the way Compass Law Group, LLP has across our personal injury practice — frequently moves a client up a tier, dramatically increasing recovery.
Source: Compass Law Group | Product Liability
Steps to Take After a Defective-Product Injury
The hours and days after you realize a medication caused harm are critical for evidence preservation. The seven steps below are based on what actually changes outcomes in California pharmaceutical cases — not on generic legal advice that pads a checklist.
- Get emergency medical care first. Call 911 or go to the nearest ER for any acute symptoms, and tell every treating provider exactly which medication you took, the dose, and how long you’ve been on it. Insist that the drug name appears in the chart.
- Preserve the medication and packaging. Keep the bottle, blister pack, outer carton, lot number, expiration date, pharmacy label, and any accompanying patient inserts. Do not flush or discard pills — the lot number is often the single most important piece of evidence.
- Collect every record. Request itemized pharmacy printouts going back at least two years, prescribing physician notes, hospital admission records, lab results, and imaging studies. Save EOBs from your insurer and any out-of-pocket receipts.
- Report the adverse event to the FDA via the MedWatch program, which feeds the FAERS database referenced earlier. Reporting does not waive any legal claim and creates a contemporaneous, government-held record of your injury.
- Do not sign anything from the manufacturer or its insurer. Initial “patient assistance” or “goodwill” payments almost always require a release of liability that extinguishes a claim worth far more.
- Document daily symptoms and limitations. A simple dated journal — pain levels, missed work, activities you can no longer perform, sleep disruption — becomes powerful evidence of non-economic damages.
- Contact a California product-liability attorney before the two-year clock runs. Compass Law Group, LLP offers free consultations at (213) 320-1001 or (800) 602-4010 and reviews dangerous-drug claims at no cost and no obligation.
How Compass Law Group Builds Your Case
Pharmaceutical litigation is uniquely document-intensive. Our team begins with a clinical timeline reconstruction — a chronological map matching every dose you took to every clinical event in your records — and pairs it with a labeling history pulled from the FDA’s Drugs@FDA database, the Orange Book, and the manufacturer’s own SEC disclosures. We then identify what the company knew, when it knew it, and what it told doctors and consumers. That comparison is what turns a difficult adverse-event story into a winnable failure-to-warn case.
From there, attorneys Joseph Shirazi (Bar #265403) and Simon Esfandi (Bar #275307) determine whether your case belongs in an existing JCCP or MDL, whether to file individually in a California superior court, or whether to negotiate a pre-suit demand. Each route has different leverage, timing, and recovery profiles. Our firm has recovered $250M+ for injury victims across product liability, premises liability, motor-vehicle, and wrongful-death cases, and we publish ongoing case-strategy explainers on our legal blog. Readers interested in how product liability principles extend beyond medications can read our companion piece on manufacturers’ liability for dangerous playground equipment, which applies the same strict-liability doctrine to children’s products.
We work on a strict No Win, No Fee basis. There is no retainer, no hourly billing, and no fee unless we recover compensation for you. Free consultations are available in person at our Los Angeles product liability headquarters in Beverly Hills and at every other California office, by phone, and by secure video.
Q: Can I sue a pharmaceutical company if my doctor prescribed the drug?
Yes. California uses the “learned intermediary” doctrine, which means the manufacturer’s duty to warn runs to your physician — but if the company failed to provide your doctor with accurate, current, and complete safety information, the manufacturer remains liable for resulting injuries. Your prescribing doctor’s good-faith reliance on inadequate labeling does not break the chain of liability. In many cases, both the drug company and a separate medical-malpractice claim against the prescriber can proceed in parallel.
Q: What if I took a generic version of the drug?
Generic-drug claims in California are more limited than branded-drug claims because federal law requires generics to use the same labeling as the brand. However, you can still pursue manufacturing-defect claims, design-defect claims under certain circumstances, and claims against the brand manufacturer under the “innovator liability” doctrine recognized in California’s T.H. v. Novartis decision. A skilled product-liability lawyer can identify the right theory for your specific medication.
Q: How long do dangerous-drug lawsuits take in California?
Individual cases typically resolve in 12 to 24 months when liability is clear and damages are documented. Cases consolidated into a JCCP or MDL can take longer — often three to five years — because they involve hundreds or thousands of plaintiffs and complex bellwether trials. The trade-off is leverage: coordinated proceedings produce settlement grids that frequently outperform what an individual plaintiff could obtain alone.
Q: What does it cost to hire Compass Law Group for a drug injury case?
Nothing upfront. Compass Law Group, LLP handles every dangerous-drug case on a contingency-fee basis — No Win, No Fee. The initial consultation is free, you owe no hourly charges, and our fee comes only out of a recovery if and when we obtain one. We also advance the costs of expert witnesses, medical-record retrieval, and litigation expenses, recouped only at the end of a successful case.
Q: What if my loved one died from a defective medication?
California Code of Civil Procedure § 377.60 allows surviving spouses, domestic partners, children, and certain other dependents to file a wrongful-death action against the drug manufacturer. Damages can include funeral and burial costs, lost financial support, lost household services, and the loss of love, companionship, and guidance. The two-year deadline runs from the date of death, not the date of original drug exposure, and a separate “survival action” under § 377.30 can also recover the decedent’s pre-death pain, suffering, and medical expenses.
Get Your Free Consultation Today
If a dangerous prescription or over-the-counter drug harmed you or someone you love, Compass Law Group, LLP will review your case at no cost — and you owe nothing unless we win. No Win, No Fee.
